Related Experiment Video
Updated: May 23, 2026

Production of Chemicals by Klebsiella pneumoniae Using Bamboo Hydrolysate as Feedstock
Published on: June 29, 2017
Production of shikimic acid
Saptarshi Ghosh1, Yusuf Chisti, Uttam C Banerjee
1Department of Pharmaceutical Technology (Biotechnology), National Institute of Pharmaceutical Education and Research, Sector-67, S.A.S. Nagar-160 062, Punjab, India.
Shikimic acid, crucial for antiviral drug synthesis, faces supply challenges from star anise. Microbial fermentation and biotransformation offer promising, scalable alternatives for its production.
Area of Science:
- Biotechnology
- Organic Chemistry
- Pharmacology
Background:
- Shikimic acid is an essential precursor for synthesizing oseltamivir (Tamiflu®), a vital antiviral medication.
- Current supply predominantly relies on extraction from Chinese star anise seeds (Illicium verum), posing significant supply chain vulnerabilities.
- Star anise cultivation involves a six-year maturation period and is susceptible to environmental factors, impacting consistent availability.
Purpose of the Study:
- To review and compare various methods for producing shikimic acid.
- To evaluate the feasibility and scalability of alternative production routes.
- To identify the most promising future strategies for shikimic acid synthesis.
Main Methods:
- Review of existing literature on shikimic acid production.
- Analysis of chemical synthesis, plant extraction, microbial fermentation, and biotransformation pathways.
- Assessment of economic viability and technological maturity of different methods.
Main Results:
- Plant extraction from star anise is currently dominant but faces supply and cost challenges.
- Microbial fermentation is an increasingly viable and scalable production method.
- Biotransformation of quinic acid presents a promising alternative route.
- Chemical synthesis and other methods are generally too expensive or underdeveloped.
Conclusions:
- Relying solely on star anise for shikimic acid is unsustainable due to supply chain risks.
- Microbial fermentation, particularly in recombinant microorganisms, is poised to become the preferred production method.
- Diversifying production strategies is crucial for ensuring a stable supply of this key pharmaceutical intermediate.
More Related Videos
Related Concept Videos
Production of Organic Acids
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
Alkylation of β-Diester Enolates: Malonic Ester Synthesis
Production of Pharmaceuticals
Products of the Citric Acid Cycle
α-Hydroxy Ketones via Reductive Coupling of Esters: Acyloin Condensation Overview

